Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 3

2(33.3%)

N/A

2(33.3%)

Phase 1

1(16.7%)

Phase 4

1(16.7%)

6Total

Phase 3(2)

N/A(2)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03500133Phase 4Recruiting

Pediatric Hodgkin Lymphoma Treatment Trial With Low Cumulative Doses of Chemotherapy Agents and Reduced Radiation.

Role: lead

NCT03475121Phase 3Completed

Treatment Protocol for Non-Metastatic Unilateral Retinoblastoma

Role: lead

NCT06408376Not ApplicableRecruiting

Physiological Umbilical Cord Clamping in Patients With Congenital Diaphragmatic Hernia. Clinical Trial

Role: lead

NCT03924570Not ApplicableCompleted

Reducing Adverse Events in Pediatric Intensive Care Units in Argentina

Role: collaborator

NCT03547050Completed

Rolandic Epilepsy Genomewide Association International Study

Role: collaborator

NCT00426101Phase 3Completed

Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004

Role: collaborator

NCT00460876Phase 1Completed

Phase I Trial of Periocular Topotecan in Retinoblastoma

Role: lead

All 7 trials loaded